LM-9

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameLM-9
Drug Alias NameLM-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloid differentiation primary response protein MyD88 inhibitors
TargetsMyeloid differentiation primary response protein MyD88
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWenzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesWenzhou Medical University
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A